HBsAg is an independent prognostic factor in diffuse large B cell lymphoma patients in rituximab era: result from a multicenter retrospective analysis in China-Reference-Cited by-同舟云学术

HBsAg is an independent prognostic factor in diffuse large B cell lymphoma patients in rituximab era: result from a multicenter retrospective analysis in China

Published:2014-01-28 Issue:3 Volume:31 Page:
ISSN:1357-0560
Container-title:Medical Oncology
language:en
Short-container-title:Med Oncol

Author:

Wei Zheng,Zou Shanhua,Li Feng,Cheng Zhixiang,Li Junmin,Wang Jianmin,Wang Chun,Chen Fangyuan,Cao Junning,Cheng Yunfeng

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,Hematology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s12032-014-0845-3.pdf

Reference21 articles.

1. Park SC, Jeong SH, Kim J, Han CJ, Kim YC, Choi KS, et al. High prevalence of hepatitis B virus infection in patients with B-cell non-Hodgkin’s lymphoma in Korea. J Med Virol. 2008;80:960–6.

2. Nath A, Agarwal R, Malhotra P, Varma S. Prevalence of hepatitis B virus infection in non-Hodgkin lymphoma: a systematic review and meta-analysis. Intern Med J. 2010;40:633–41.

3. Wang F, Xu RH, Han B, Shi YX, Luo HY, Jiang WQ, et al. High incidence of hepatitis B virus infection in B-cell subtype non-Hodgkin lymphoma compared with other cancers. Cancer. 2007;109:1360–4.

4. Marcucci F, Mele A. Hepatitis viruses and non-Hodgkin lymphoma: epidemiology, mechanisms of tumorigenesis, and therapeutic opportunities. Blood. 2011;117:1792–8.

5. Engels EA, Cho ER, Jee SH. Hepatitis B virus infection and risk of non-Hodgkin lymphoma in South Korea: a cohort study. Lancet Oncol. 2010;11:827–34.

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Carcinogenic mechanisms of virus-associated lymphoma;Frontiers in Immunology;2024-02-28

2. Hepatitis B surface antigen positivity is associated with poor short- and long-term outcomes in patients with diffuse large B-cell lymphoma who received CHOP or R-CHOP;Frontiers in Immunology;2024-01-22

3. HBV-associated DLBCL of poor prognosis: advance in pathogenesis, immunity and therapy;Frontiers in Immunology;2023-07-07

4. Treated chronic hepatitis B is a good prognostic factor of diffuse large B-cell lymphoma;Clinical and Molecular Hepatology;2023-07-01

5. Hepatitis Virus-associated Non-hodgkin Lymphoma: Pathogenesis and Treatment Strategies;Journal of Clinical and Translational Hepatology;2023-05-30